한글목차

세계의 계약 연구 기관 시장은 2024년에 521억 5,000만 달러로 평가되었고, 2030년까지는 681억 5,000만 달러에 이를것으로 예측되며, CAGR 4.76%로 성장할 전망입니다.

약물 개발과 관련된 복잡성, 비용 증가, 규제 감독 강화가 시장 성장의 주요 요인으로 작용하고 있습니다. 제약 및 바이오기술 기업들은 글로벌 규제 프레임워크를 준수하면서 개발 일정 단축과 비용 관리에 대한 압력을 받고 있습니다. 이를 위해 많은 기업들이 임상 및 전임상 연구 기능을 CRO에 아웃소싱하고 있습니다. CRO는 전문적인 전문성, 글로벌 인프라, 최첨단 기술을 제공하기 때문입니다. CRO는 개발 워크플로우 최적화, 규제 준수 관리, 연구 노력의 확장성 확보에서 핵심적인 역할을 수행합니다. 그러나 시장 성장은 경쟁 압력, 지역별 규제 환경의 변화, 엄격한 데이터 무결성 및 우수 임상실습(GCP) 준수 요구사항으로 인해 제약을 받고 있습니다. 이러한 도전에도 불구하고 CRO는 점점 더 글로벌화되는 제약 산업에서 비용 효율적이고 효율적인 연구 서비스를 제공하는 전략적 파트너로 계속해서 자리매김하고 있습니다.

주요 시장 성장 촉진요인

의료 산업의 성장

주요 시장 과제

임상시험 비용 상승

주요 시장 동향

바이오시밀러 및 바이오의약품 임상 시험 증가

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 개발 업무 수탁 기관 시장에 대한 COVID-19의 영향

제5장 세계의 계약 연구 기관 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 서비스별(초기 단계 개발 서비스, 임상 조사 서비스, 랩 서비스, 컨설팅 서비스, 데이터 관리 서비스)
  • 용도별(종양학, 중추신경계, 심혈관계, 호흡기, 감염증, 자가면역 질환, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 계약 연구 기관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 개발 업무 수탁 기관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 계약 연구 기관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 계약 연구 기관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 계약 연구 기관 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 합병과 인수
• 제품 출시
• 최근 동향

제13장 혼란 : 분쟁, 유행, 무역 장벽

제14장 세계의 계약 연구 기관 시장 : SWOT 분석

제15장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제16장 경쟁 구도

• GE HealthCare Technologies Inc.
• Abbott Laboratories
• Agilent Technologies, Inc.
• PerkinElmer Inc.
• Standard BioTools Inc.
• Illumina, Inc.
• Bio-Rad Laboratories Inc.
• Cepheid Inc.
• Thermo Fisher Scientific, Inc.
• Qiagen NV

제17장 전략적 제안

제18장 기업 소개 및 면책사항

영문목차

The Global Contract Research Organization Market was valued at USD 52.15 Billion in 2024 and is projected to reach USD 68.15 Billion by 2030, growing at a CAGR of 4.76%. The increasing complexity, cost, and regulatory scrutiny associated with drug development are key factors fueling the market's growth. Pharmaceutical and biotechnology companies are facing mounting pressure to accelerate development timelines and manage expenses while complying with global regulatory frameworks. To achieve this, many are outsourcing clinical and preclinical research functions to CROs, which offer specialized expertise, global infrastructure, and cutting-edge technologies. CROs play a pivotal role in streamlining development workflows, managing compliance, and enabling scalability in research efforts. However, market growth is tempered by competitive pressures, evolving regulatory landscapes across regions, and the need for stringent data integrity and Good Clinical Practice (GCP) compliance. Despite these challenges, CROs continue to be strategic partners in delivering cost-effective and efficient research services across an increasingly globalized pharmaceutical landscape.

Key Market Drivers

Growth in Healthcare Industry

The rapid expansion of the global healthcare industry is a major driver of the Contract Research Organization market. Rising investments in biopharmaceutical R&D, increasing focus on personalized medicine, and an expanding portfolio of therapeutic innovations are prompting pharmaceutical and medical device companies to seek external support from CROs. Countries such as Finland, Belgium, and Japan are leading with highly efficient healthcare systems, while even advanced markets like the U.S. face ongoing challenges in cost and care accessibility. With millions remaining uninsured and healthcare systems under pressure, pharmaceutical companies are leveraging CROs to improve efficiency and minimize development risks. CROs offer a range of services-spanning early-stage discovery to post-market surveillance-that help sponsors navigate complex clinical and regulatory environments. As healthcare demands rise, so does the need for efficient outsourcing solutions that CROs are well-positioned to provide.

Key Market Challenges

Rising Cost of Clinical Trials

Escalating costs associated with conducting clinical trials present a significant challenge for the CRO industry. As trial protocols become more complex, involving diverse geographies, larger patient populations, and advanced data requirements, the financial burden on sponsors and service providers increases. Additional costs stem from the integration of high-end technologies, including biomarker analysis, genomic profiling, and real-time data monitoring tools-all of which require significant investment in infrastructure and expertise. Logistical complexities associated with managing global trial sites and ensuring regulatory compliance across jurisdictions add further operational strain. For CROs, balancing cost-efficiency with quality service delivery remains a critical concern, particularly when servicing cost-sensitive clients or navigating budget constraints in emerging markets.

Key Market Trends

Rise in Biosimilars and Biologics Trials

The expanding focus on biosimilars and biologics is reshaping the global CRO landscape. The expiration of patents on high-value biologic drugs has opened opportunities for biosimilar development, especially in markets like India that offer cost-effective research ecosystems and supportive regulatory structures. India is increasingly recognized as a preferred location for biosimilar trials due to its skilled workforce and favorable clinical infrastructure. Meanwhile, the rise of complex biologics-including monoclonal antibodies, vaccines, and gene therapies-requires specialized research capabilities. CROs equipped to handle bioanalytical testing, immunogenicity evaluation, and biomarker analysis are in high demand as sponsors look for end-to-end biologics expertise. This trend reflects a broader shift toward advanced therapies and precision medicine, with CROs playing a vital role in accelerating development and navigating the regulatory complexities of modern biologics.

Key Market Players

• GE HealthCare Technologies Inc.
• Abbott Laboratories
• Agilent Technologies, Inc.
• PerkinElmer Inc.
• Standard BioTools Inc.
• Illumina, Inc.
• Bio-Rad Laboratories Inc.
• Cepheid Inc.
• Thermo Fisher Scientific, Inc.
• Qiagen N.V.

Report Scope

In this report, the Global Contract Research Organization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contract Research Organization Market, By Service:

• Early Phase Development Services
• Clinical Research Services
• Laboratory Services
• Consulting Services
• Data Management Services

Contract Research Organization Market, By Application:

• Oncology
• Central Nervous System
• Cardiovascular
• Respiratory
• Infectious Diseases
• Autoimmune Disorders
• Others

Contract Research Organization Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Contract Research Organization Market.

Available Customizations

Global Contract Research Organization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Contract Research Organization Market

5. Global Contract Research Organization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Early Phase Development Services, Clinical Research Services, Laboratory Services, Consulting Services, Data Management Services)
  • 5.2.2. By Application (Oncology, Central Nervous System, Cardiovascular, Respiratory, Infectious Diseases, Autoimmune Disorders, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Contract Research Organization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Contract Research Organization Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Contract Research Organization Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Contract Research Organization Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Application

7. Europe Contract Research Organization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Contract Research Organization Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Contract Research Organization Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Contract Research Organization Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Contract Research Organization Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Contract Research Organization Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Application

8. Asia Pacific Contract Research Organization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Contract Research Organization Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Application
  • 8.3.2. India Contract Research Organization Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Contract Research Organization Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Contract Research Organization Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Contract Research Organization Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Application

9. South America Contract Research Organization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Contract Research Organization Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Contract Research Organization Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Contract Research Organization Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Application

10. Middle East and Africa Contract Research Organization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Contract Research Organization Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Contract Research Organization Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Contract Research Organization Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Contract Research Organization Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. GE HealthCare Technologies Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Abbott Laboratories
• 16.3. Agilent Technologies, Inc.
• 16.4. PerkinElmer Inc.
• 16.5. Standard BioTools Inc.
• 16.6. Illumina, Inc.
• 16.7. Bio-Rad Laboratories Inc.
• 16.8. Cepheid Inc.
• 16.9. Thermo Fisher Scientific, Inc.
• 16.10. Qiagen N.V.

17. Strategic Recommendations

18. About Us & Disclaimer